The heart
In cats with subclinical hypertrophic cardiomyopathy, a delayed-release rapamycin formulation was associated with slower progression of left ventricular wall thickening. It slows the disease; it does not reverse it.
She doesn’t make the jump to the window ledge in one go anymore.
The 2am sprint down the hallway stopped happening months ago.
She still purrs when you come home. She just takes a little longer to get there.
None of that is “just old age”. It is biology — and for the first time, biology we can act on.
For most of veterinary history there wasn’t. You brought your cat in, the bloodwork came back “normal for her age”, and you went home with nothing to do but watch.
You are the kind of owner who reads the lab values. Who notices the change in the jump before anyone else does. Who has already done the arithmetic on how many years are likely left.
That instinct was right. What has changed is that the biology of feline aging is now a target — not a metaphor.
cats over nine are affected by heart disease — and roughly a third of them have no murmur at all.
Hypertrophic cardiomyopathy is the most common feline heart disease. In cats with subclinical HCM, a delayed-release rapamycin formulation has been associated with slower progression of wall thickening.
Lifespan is a number on a chart. Healthspan is whether she still does the things that make her recognisably herself.
Rapamycin acts on mTOR — the pathway that decides whether cells grow or repair themselves. Here is what that means organ by organ, with the evidence stated honestly.
In cats with subclinical hypertrophic cardiomyopathy, a delayed-release rapamycin formulation was associated with slower progression of left ventricular wall thickening. It slows the disease; it does not reverse it.
Chronic kidney disease is the most common serious illness of older cats, driven by fibrosis. mTOR signalling participates in that fibrosis, and clinical studies in cats are underway — no protocol has yet been shown to change the course of feline CKD.
mTOR inhibition is an established anticancer mechanism in human oncology, and preliminary signals have been reported in feline mammary and squamous cell carcinomas. Evidence in cats remains limited.
Partial mTOR inhibition activates autophagy — the cell’s cleanup process — which is associated with lower chronic inflammation. In laboratory species this translates into longer healthy lifespan.
Her owner brought her in for a dental. The vet heard a gallop rhythm, and the echocardiogram found what the stethoscope suspected: hypertrophic cardiomyopathy, still subclinical. No signs. No symptoms. A heart wall already thicker than it should be.
The conversation that follows that diagnosis used to be short. Monitor. Recheck in six months. Hope it stays slow.
Instead her cardiologist and our veterinary team built a protocol: weight-calibrated, once-weekly, with echocardiography tracking the thing that actually matters. Eighteen months on, Sisu is thirteen, and the wall measurement has held.
One cat’s course is not a result you should expect. Individual outcomes vary, and this story is not a medical claim.
Most cats we start are healthy. The point is to act before there is a crisis to react to.
It is not right for every cat. Diabetes or impaired glucose regulation, active infection, significant liver disease, planned surgery, or pregnancy all rule it out — which is exactly what the veterinary review checks before anything is prescribed.
The molecule is the easy part. What makes it work — and what makes it safe — is everything around it.
0.4 mg, 1.2 mg or 2.4 mg, scaled to body weight. Longevity dosing is a fraction of the dose used in transplant medicine, and it is intermittent rather than daily.
A delayed-release, acid-resistant tablet. Flavoured oral suspensions exist for cats that refuse tablets — the protocol only works if it is actually given.
Health history, current medications and baseline bloodwork. Rapamycin is metabolised through CYP3A4, so interactions are checked rather than assumed.
Periodic bloodwork, weight, and where HCM is involved, echocardiography — measuring the wall itself, not just how she seems.
Given properly, this is a monitored medical protocol. Given without oversight — wrong dose, no screening, no bloodwork, unchecked interactions — it is neither safe nor useful. That difference is the whole service.
Rapamycin is a prescription medicine. Every route below ends with a licensed veterinarian making the call.
Already have a vet who knows your cat? Bring them the protocol. We will share dosing guidance and monitoring schedules so everyone stays aligned.
Read the science →The veterinary review, a protocol calibrated to your cat, ongoing monitoring, and the next box shipping automatically as the current one runs out — 10% below the single-box price, with nothing to reorder. This is where most owners start.
View the cat therapy →Prefer to start with one box and decide later? The same veterinary review applies, with nothing recurring.
View the cat therapy →What is another two good years with her worth? We can’t price that. We can tell you what the programme costs, and exactly what is in it.
Longevity medicine is not about getting hold of a molecule. It is about the right dose, the right monitoring, at the right time — and knowing when the answer is no. Every Rapavie protocol is designed and overseen by veterinarians experienced in feline longevity medicine. We are not selling pills. We are building a medical relationship that adapts as your cat ages.
Start with the veterinary review. If your cat is not a candidate, we will tell you — that answer is part of the service too.
This page is educational and is not veterinary advice. Rapamycin is a prescription medicine; whether to use it is a decision made with a veterinarian who has examined your animal. No medicine is licensed to “extend longevity” — the statements here describe published research and ongoing studies.